Clinical Study
Ferric Citrate: A Study Drug for Children and Teenagers with Hyperphosphatemia from Chronic Kidney Disease
Chronic Kidney disease can cause Hyperphosphatemia (extra phosphate in the blood). Ferric Citrate is a study drug for children and teenagers with this condition. We are trying to find out if the study drug can safely lower the amount of phosphate in the blood of children and teenagers. The information we gain may aid future patients.
For more information contact:
Richard Drake
richard.drake@hsc.utah.edu
801-213-8678
IRB#: IRB_00161276
| PI: Raoul Nelson
| Department: PEDIATRICS
| Approval Date: 2023-06-21 06:00:00
Specialties: Pediatric Nephrology
Who can participate?
Gender: All
Age: 7 to 17 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria:
- Ages 12 to 17 years old
- Diagnosed with chronic kidney disease that requires dialysis. Or not on dialysis with specific measures
- Attend in person at the University of Utah
Exclusion Criteria:
- Active GI (stomach) disorder
- Unable to swallow pills
- Use a feeding tube
- Active drug or alcohol dependence or abuse
- Pregnant
Will I be paid for my time?
Yes